Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck KGaA Sticks With Structure, Eyes Smaller Healthcare Deals

09 Nov 2023

• By Kevin Grogan

Helene von Roeder — Helene von Roeder • Source: Merck KGaA

Related Content

Sanofi Stock Slides On Lower Profit Forecast And Consumer Health Spinoff Plan

27 Oct 2023

Bayer To Split Off Consumer Or Crop Science, Or Both, Or Neither

08 Nov 2023

Sandoz Stands Alone As It Completes Novartis Spinoff

04 Oct 2023

Clinical Hold For Merck KGaA’s BTK Inhibitor Evobrutinib For MS Raises Class Safety Fears

12 Apr 2023

ESMO 23: Madrid Meeting Hails Padcev/Keytruda Combo As New Bladder Cancer Standard Of Care

23 Oct 2023

Related Companies

Bayer AG

Sanofi

Merck KGaA

Johnson & Johnson

Pfizer Inc.

GSK plc

Novartis AG

Sandoz Inc.

Procter & Gamble

Jiangsu Hengrui Pharmaceuticals

AstraZeneca PLC

Seagen Inc.

Astellas Pharma, Inc.

Merck & Co., Inc.

Additional Topics

Sales & Earnings Business Strategies Clinical Trials Commercial Cancer BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.